In this roundtable discussion published in Corporate Disputes, Sean Sheridan and two other panelists discuss recent trends in patent disputes. Dr. Sheridan dicusses the sharp decline in petitions for inter partes review filed at the Patent Trial and Appeal Board (PTAB) as well an an increase in the number of bills seeking to limit patent protection for pharmaceutical and biologic products.
Click the link below to download a PDF of the article.
CRA expands its Intellectual Property Practice
CRA has expanded its Intellectual Property Practice with the addition of 20 consultants including Chris Bakewell and Julia Rowe, who have joined the firm as...